2 results
Approved WMOCompleted
The primary objective of this study is to evaluate the tumor response of stable disease (SD), partial response, or complete response at at 12 weeks (according to RECIST 1.1 criteria) in two separate cohorts representing molecularly distinct subsets…
Approved WMORecruiting
To test the impact of the addition of axitinib to standard chemotherapy treatment on histology samples